Common shares of Coherus BioSciences, Inc., trading on the NASDAQ exchange under the ticker symbol CHRS, maintain a market valuation hovering around $1.37 per share. Stock quotes fluctuate continuously throughout active trading sessions based on daily market liquidity, institutional order matching, biotech sector sentiment, and periodic corporate earnings releases. Market participants tracking the security for investment purposes should consult live financial market data platforms right before executing trades to account for real-time intraday price movements.